Background
==========

Cryo plus anti-CTLA-4 therapy induces antigen-specific clonal T cell expansion, enhanced survival, and long-term anti-tumor immunity in mice \[[@B1]\]. We recently demonstrated that pre-operative cryo and/or anti-CTLA-4 therapy with Ipi is well tolerated and clinically feasible in women with ESBC. Furthermore, cryo with or without Ipi generates a polyclonal influx of novel T cell clones within the tumor bed \[[@B2],[@B3]\]. Here, we utilize T cell repertoire analysis to explore the impact of cryo and/or Ipi on clonal expansion within peripheral blood and TILs.

Methods
=======

In a pilot study, women with ESBC were treated with cryo 7-10d before mastectomy (6 pts), single-dose Ipi (10 mg/kg) 8-15d before mastectomy (6 pts), or cryo+Ipi (6 pts). Peripheral blood mononuclear cells (PBMCs) and tumor tissue were obtained pre-mastectomy (immediately preceding cryo and/or 1-5d after Ipi), and at mastectomy. T cell repertoire analysis was conducted on extracted DNA using an Illumina^®^ DNA deep sequencing platform and ImmunoSEQ™ software. Clones comprising ≥0.01% of sample DNA were analyzed, and results are reported descriptively.

Results
=======

Cryo with or without Ipi was associated with decreases in absolute TIL count (median change: Ipi +6%, cryo -73%, cryo+Ipi -16%). However, cryo+Ipi was associated with the greatest expansion of TIL clones across the range of 10^2^-10^4^amplicons (table [1](#T1){ref-type="table"}), although no difference was observed by group in PBMC clones. Across all samples, a median of 523 TIL clones increased by ≥10^2^amplicons, and a median of 4 TIL clones increased by ≥10^3^amplicons. The Ipi/cryo group exceeded the median in 80% (4/5) of cases. 21% of all TIL clones were detectable in time-matched PBMC, whereas 16% of expanding (≥10^2^) TIL clones were detectable in time-matched PBMC.

###### 

Therapy-associated T cell clonal expansion in TILs and PBMCs.

                 Median \# TIL clones expanding by   Median \# PBMC clones expanding by                                                         
  -------------- ----------------------------------- ------------------------------------ ----------------- ----------------- ----------------- -----------------
                 ≥10^2^amplicons                     ≥10^3^amplicons                      ≥10^4^amplicons   ≥10^2^amplicons   ≥10^3^amplicons   ≥10^4^amplicons
  **Cryo**       199                                 2                                    0                 697               1                 0
  **Ipi**        750                                 22                                   1                 545               5                 0
  **Cryo+Ipi**   2010                                85                                   1                 830               1                 0

Conclusion
==========

Cryo plus Ipi expands more TIL clones than either strategy alone. Therapy-associated clonal expansion may be difficult to detect in PBMCs. These data highlight the potential importance of TIL repertoire analysis for the monitoring of pts treated with cryo and/or Ipi in the preoperative setting. In a follow-up randomized study, we will evaluate whether TIL clonal expansion across the 10^2^-10^4^range can be used to predict recurrence-free survival.
